| Phase II trial of bicalutamide in patients with androgen receptor–positive, estrogen receptor–negative metastatic breast cancer A Gucalp, S Tolaney, SJ Isakoff, JN Ingle, MC Liu, LA Carey, K Blackwell, ... Clinical cancer research 19 (19), 5505-5512, 2013 | 823 | 2013 |
| An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen AS Doane, M Danso, P Lal, M Donaton, L Zhang, C Hudis, WL Gerald Oncogene 25 (28), 3994-4008, 2006 | 678 | 2006 |
| CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas Y Jiang, A Ortega-Molina, H Geng, HY Ying, K Hatzi, S Parsa, D McNally, ... Cancer discovery 7 (1), 38-53, 2017 | 257 | 2017 |
| Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture N Yusufova, A Kloetgen, M Teater, A Osunsade, JM Camarillo, CR Chin, ... Nature 589 (7841), 299-305, 2021 | 181 | 2021 |
| The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study M Shike, AS Doane, L Russo, R Cabal, JS Reis-Filho, W Gerald, H Cody, ... Journal of the National Cancer Institute 106 (9), dju189, 2014 | 156 | 2014 |
| TET2 deficiency causes germinal center hyperplasia, impairs plasma cell differentiation, and promotes B-cell lymphomagenesis PM Dominguez, H Ghamlouch, W Rosikiewicz, P Kumar, W Béguelin, ... Cancer discovery 8 (12), 1632-1653, 2018 | 147 | 2018 |
| Widespread mitotic bookmarking by histone marks and transcription factors in pluripotent stem cells Y Liu, B Pelham-Webb, DC Di Giammartino, J Li, D Kim, K Kita, N Saiz, ... Cell reports 19 (7), 1283-1293, 2017 | 134 | 2017 |
| 18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis JR Osborne, E Port, M Gonen, A Doane, H Yeung, W Gerald, JB Cook, ... Journal of Nuclear Medicine 51 (4), 543-550, 2010 | 126 | 2010 |
| CHD1 loss alters AR binding at lineage-specific enhancers and modulates distinct transcriptional programs to drive prostate tumorigenesis MA Augello, D Liu, LD Deonarine, BD Robinson, D Huang, S Stelloo, ... Cancer Cell 35 (4), 603-617. e8, 2019 | 107 | 2019 |
| Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response X Agirre, C Meydan, Y Jiang, L Garate, AS Doane, Z Li, A Verma, B Paiva, ... Nature communications 10 (1), 821, 2019 | 86 | 2019 |
| Stat3 mediates expression of autotaxin in breast cancer J Azare, A Doane, K Leslie, Q Chang, M Berishaj, J Nnoli, K Mark, ... PloS one 6 (11), e27851, 2011 | 76 | 2011 |
| The NF-κB transcriptional footprint is essential for SARS-CoV-2 replication BE Nilsson-Payant, S Uhl, A Grimont, AS Doane, P Cohen, RS Patel, ... Journal of Virology 95 (23), 10.1128/jvi. 01257-21, 2021 | 75 | 2021 |
| Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis K Hatzi, H Geng, AS Doane, C Meydan, R LaRiviere, M Cardenas, C Duy, ... Nature immunology 20 (1), 86-96, 2019 | 74 | 2019 |
| Regulatory elements in molecular networks AS Doane, O Elemento Wiley Interdisciplinary Reviews: Systems Biology and Medicine 9 (3), e1374, 2017 | 37 | 2017 |
| Extracellular matrix in synthetic hydrogel‐based prostate cancer organoids regulate therapeutic response to EZH2 and DRD2 inhibitors MJ Mosquera, S Kim, R Bareja, Z Fang, S Cai, H Pan, M Asad, ML Martin, ... Advanced Materials 34 (2), 2100096, 2022 | 34 | 2022 |
| CREBBP inactivation promotes the development of HDAC3-dependent lymphomas. Cancer Discov. 2017; 7: 38–53. doi: 10.1158/2159-8290 Y Jiang, A Ortega-Molina, H Geng, HY Ying, K Hatzi, S Parsa, D McNally, ... CD-16-0975.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 31 | |
| Unique immune cell coactivators specify locus control region function and cell stage CS Chu, JC Hellmuth, R Singh, HY Ying, L Skrabanek, MR Teater, ... Molecular cell 80 (5), 845-861. e10, 2020 | 30 | 2020 |
| Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation MA Rivas, C Meydan, CR Chin, MF Challman, D Kim, B Bhinder, ... Nature immunology 22 (2), 240-253, 2021 | 29 | 2021 |
| OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity AS Doane, CS Chu, DC Di Giammartino, MA Rivas, JC Hellmuth, Y Jiang, ... Nature immunology 22 (10), 1327-1340, 2021 | 13 | 2021 |
| BTG1 mutation yields supercompetitive B cells primed for malignant transformation C Mlynarczyk, M Teater, J Pae, CR Chin, L Wang, T Arulraj, D Barisic, ... Science 379 (6629), eabj7412, 2023 | 12 | 2023 |
Olivier ElementoDirector, Englander Institute for Precision Medicine, Weill Cornell MedicineVerified email at med.cornell.edu
